The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma

Acta Oncologica

Volumn 52, Issue 7, 2013, Pages 1559-1565

  Jorgensen, Anni Y S ^a   Maraldo, Maja V ^a   Brodin, Nils Patrik ^a,b   Aznar, Marianne C ^a,b   Vogelius, Ivan R ^a   Rosenschold P M A ^a,b   Petersen, Peter M ^a   Specht, Lena ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER RADIOTHERAPY; CHEMOTHERAPY; CLINICAL ARTICLE; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; ESOPHAGUS STENOSIS; FEMALE; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MANTLE FIELD RADIOTHERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RADIATION RESPONSE; RISK ASSESSMENT; STATISTICAL ANALYSIS; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; VOLUMETRIC MODULATED ARC THERAPY; ADOLESCENT; CANCER PATIENT; DOSE RESPONSE; ESOPHAGUS; INVOLVED NODE RADIOTHERAPY; RADIATION DOSE; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY;

ADOLESCENT; ADULT; AGED; ESOPHAGITIS; ESOPHAGUS; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANS AT RISK; PROGNOSIS; PROTON THERAPY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84884562924     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.813636     Document Type: Article

References (24)

1. National Cancer Institute. S EER State Fact Sheets: Hodgkin Lymphoma. SEER Cancer Statistics Review November 2011. [Internet]. Available from: Http://seer.cancer.gov/ statfacts/html/hodg.html. [cited 2013 Jan 14
2. Eich HT, Diehl V, Gorgen H, Pabst T, Markova J, Debus J, et al. Intensifi ed chemotherapy and dose-reduceDinvolved-fi eld radiotherapy in patients with earlYunfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol 2010;28:4199-206
3. Engert A, Plutschow A, Eich H T, Lohri A, Dorken B, Borchmann P, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 2010;363:640-52
4. Aleman B M, Van Den Belt-Dusebout AW, Klokman W J, Van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specifi c mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003;21:3431-9
5. Aleman BM, Van Den Belt-Dusebout A W, De Bruin ML, van ' t Veer MB, Baaijens MH, de Boer JP, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109:1878-86
6. Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002;20:2101-8
7. Girinsky T, Van Der Maazen R, Specht L, Aleman B, Poortmans P, Lievens Y, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines. Radiother Oncol 2006;79:270-7
8. Maraldo M V, Aznar M C, Vogelius I R, Petersen PM, Specht L. Involved node radiation therapy: An effective alternative in early-stage Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2013;85:1057-65
9. Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks LB. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S86-93
10. Morton L M, Gilbert E S, Hall P, Andersson M, Joensuu H, VaalavirtAl, et al. Risk of treatment-relateDesophageal cancer among breast cancer survivors. Ann Oncol 2012;23:3081-91
11. Ellenhorn JD, Lambroza A, Lindsley KL, LaQuaglia MP. Treatment-related sophageal stricture in pediatric patients with cancer. Cancer 1993;71:4084-90
12. Mahboubi S, Silber JH. Radiation-induceDesophageal strictures in children with cancer. Eur Radiol 1997;7:119-22
13. Schiavetti A, Di NG, Ingrosso A, Chiriaco D, Cucchiara S. Barrett esophagus in long-term survivors of childhood solid tumors. J Pediatr HematoLoncol 2011;33:559-61
14. Micke O, Schafer U, Glashorster M, Prott F J, Willich N. Radiation-induceDesophageal carcinoma 30 years after mediastinaLirradiation: Case report and review of thEliterature . Jpn J Clin Oncol 1999;29:164-70
15. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy . Radiother Oncol 2005;75:157-64
16. Alevronta E, Ahlberg A, Mavroidis P, al-A bany M, Friesland S, Tilikidis A, et al. Dose-response relations for stricture in the proximaLoesophagus from head and neck radiotherapy. Radiother Oncol 2010;97:54-9
17. Maraldo M V, Brodin N P, Vogelius I R, Aznar M C, Munck af RP, Petersen PM, et al. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle fi eld for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2012;83:1232-7
18. Maraldo M V, Brodin N P, Aznar M C, Vogelius I R, Munck af RP, Petersen PM, et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann OncoLepub 2013 Apr 25
19. Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, et al. Predictors of high-grade esophagitis after defi nitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012;84:1010-6
20. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine L.S., Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S10-9
21. Lawson J D, Otto K, Grist W, Johnstone P A. F requency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol 2008;29:13-9
22. Ahn SJ, Kahn D, Zhou S, Yu X, Hollis D, Shafman TD, et al. Dosimetric and clinical predictors for radiation-induceDesophageaLinjury. Int J Radiat Oncol Biol Phys 2005;61:335-47
23. Chudecki B. Radiation cancer of the thoracic oesophagus. Br J Radiol 1972;45:303-4
24. Fiandra C, Filippi A R, Catuzzo P, Botticella A, Ciammella P, Franco P, et al. Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's lymphoma: Dosimetric comparison and clinical considerations. Radiat Oncol 2012;7:186